YAP1 and melanoma: More recently, SRC activation was shown to increase YAP/TAZ activity by repressing LATS in breast cancer and melanoma cells through inactivation of GPCR-kinase-interacting protein 1 (GIT1), which, in turn, promotes the LATS-mediated phosphorylation of YAP [47].